Company
EMvision Medical Devices Limited
Headquarters: Macquarie Park, NSW, Australia
CEO: Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D.
Market Cap
A$169.6 Million
AUD as of July 1, 2024
US$112.9 Million
EMvision Medical Devices Limited Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for point of care, stroke diagnosis, and monitoring. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Stocks & Indices
EMvision Medical Devices Limited has the following listings and related stock indices.
Stock: ASX: EMV wb_incandescent